Showing results (641-650 of 6,299) with videos related to
Sort By:
Pageof 630
Diabetes, Obesity & Metabolism|June 17, 2006
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetesL Blonde, E J Klein, J Han, et al.Diabetes, Obesity & Metabolism|June 17, 2006
A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agentsS J Jacober, J L Scism-Bacon, A J ZagarDiabetes, Obesity & Metabolism|March 27, 2009
A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stressS E Siegelaar, W Kulik, H van Lenthe, et al.Diabetes, Obesity & Metabolism|November 12, 2013
A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylureaR G Moses, S Kalra, D Brook, et al.Diabetes, Obesity & Metabolism|November 12, 2013
Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cellsS Bhattacharya, N Oksbjerg, J F Young, et al.Diabetes, Obesity & Metabolism|October 15, 2013
Obesity paradox in people newly diagnosed with type 2 diabetes with and without prior cardiovascular diseaseG Thomas, K Khunti, V Curcin, et al.Diabetes, Obesity & Metabolism|October 15, 2013
Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trialH Denison, C Nilsson, L Löfgren, et al.Diabetes, Obesity & Metabolism|October 15, 2013
Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injectionsM C Riddle, J Rosenstock, A Vlajnic, et al.Diabetes, Obesity & Metabolism|December 2, 2008
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugsM R Lankisch, K C Ferlinz, J L Leahy, et al.Diabetes, Obesity & Metabolism|September 11, 2007
Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box?A Liew, J H McDermott, F Barry, et al.Pageof 630